| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 184,6 k € | +9.9% | 168,0 k € | +16.6% | 144,0 k € | +34.8% | 106,8 k € | -32.7% | 158,7 k € | +82.4% | 87,0 k € | +1.3% | 85,9 k € | -4.3% | 89,7 k € | -13.4% | 103,6 k € | +26.1% | 82,2 k € | -16.6% | 98,6 k € | +70.7% | 57,8 k € | -45.2% | 105,4 k € | -10.1% | 117,2 k € | +1.2% | 115,8 k € | +26.8% | 91,3 k € | +30.2% | 70,2 k € | -8.4% | 76,6 k € | -21.0% | 97,0 k € | |
| EBITDA | 184,2 k € | +10.2% | 167,1 k € | +16.4% | 143,6 k € | +38.4% | 103,7 k € | -33.2% | 155,4 k € | +83.4% | 84,7 k € | +0.8% | 84,1 k € | -4.1% | 87,6 k € | -15.0% | 103,1 k € | +29.0% | 79,9 k € | -17.5% | 96,8 k € | +75.4% | 55,2 k € | -46.4% | 102,8 k € | -10.6% | 115,1 k € | +1.5% | 113,4 k € | +28.9% | 88,0 k € | +27.8% | 68,8 k € | +1.3% | 67,9 k € | -26.3% | 92,2 k € | |
| Operating profit | 180,9 k € | +16.7% | 155,0 k € | +18.0% | 131,4 k € | +51.6% | 86,7 k € | -36.6% | 136,8 k € | +111.7% | 64,6 k € | +46.1% | 44,2 k € | -6.5% | 47,3 k € | -30.0% | 67,6 k € | +53.1% | 44,1 k € | -25.3% | 59,1 k € | +228.1% | 18,0 k € | -71.7% | 63,7 k € | -13.7% | 73,8 k € | +1.8% | 72,4 k € | +58.2% | 45,8 k € | +35.6% | 33,8 k € | -2.1% | 34,5 k € | -46.8% | 64,8 k € | |
| Profit/loss | 119,4 k € | +16.7% | 102,3 k € | +18.9% | 86,1 k € | +40.8% | 61,1 k € | -34.1% | 92,7 k € | +89.8% | 48,8 k € | +65.6% | 29,5 k € | +5.7% | 27,9 k € | -34.2% | 42,4 k € | +68.7% | 25,1 k € | -22.4% | 32,4 k € | +404.3% | 6,4 k € | -83.7% | 39,3 k € | -7.0% | 42,2 k € | +5.7% | 40,0 k € | +44.1% | 27,7 k € | +82.4% | 15,2 k € | +0.3% | 15,2 k € | -55.7% | 34,2 k € | |
| Equity | 478,0 k € | +33.3% | 358,6 k € | +39.9% | 256,3 k € | +50.6% | 170,2 k € | +33.3% | 127,7 k € | +80.6% | 70,7 k € | +6.8% | 66,2 k € | +32.3% | 50,0 k € | -23.2% | 65,1 k € | -21.3% | 82,8 k € | +13.9% | 72,7 k € | +8.0% | 67,3 k € | -40.9% | 113,9 k € | +8.9% | 104,6 k € | +67.7% | 62,4 k € | +23.8% | 50,4 k € | -7.8% | 54,7 k € | +38.5% | 39,5 k € | -68.3% | 124,3 k € | |
| Total assets | 503,9 k € | +25.6% | 401,3 k € | +34.3% | 298,7 k € | +39.7% | 213,8 k € | +7.4% | 199,1 k € | +40.2% | 142,0 k € | +11.7% | 127,2 k € | -10.0% | 141,4 k € | -17.9% | 172,1 k € | -17.8% | 209,4 k € | -6.1% | 223,1 k € | +6.7% | 209,1 k € | -24.7% | 277,8 k € | -6.9% | 298,5 k € | +2.8% | 290,4 k € | -6.3% | 309,8 k € | -6.6% | 331,7 k € | -8.7% | 363,2 k € | -15.8% | 431,6 k € | |
| Cash | 178,9 k € | +0.7% | 177,7 k € | +43.2% | 124,1 k € | -3.2% | 128,2 k € | +16.1% | 110,4 k € | +66.3% | 66,4 k € | +8.6% | 61,1 k € | +58.1% | 38,7 k € | +9.2% | 35,4 k € | -29.2% | 50,0 k € | +4.4% | 47,9 k € | +33.4% | 35,9 k € | -3.5% | 37,2 k € | -10.3% | 41,5 k € | -8.9% | 45,5 k € | +55.2% | 29,3 k € | -60.7% | 74,6 k € | -7.8% | 80,9 k € | -49.2% | 159,5 k € | |
| Debts | 26,0 k € | -39.1% | 42,7 k € | +0.5% | 42,5 k € | -2.6% | 43,6 k € | -39.0% | 71,5 k € | +0.2% | 71,3 k € | +16.9% | 61,0 k € | -33.2% | 91,3 k € | -14.6% | 107,0 k € | -15.5% | 126,6 k € | -15.8% | 150,4 k € | +6.1% | 141,7 k € | -13.5% | 163,9 k € | -15.5% | 193,9 k € | -15.0% | 228,1 k € | -12.1% | 259,4 k € | -6.4% | 277,1 k € | -14.4% | 323,7 k € | +5.4% | 307,3 k € | |
Private limited company · Asse · incorporated on 04/01/2001
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR LUC MOENS, HUISARTS is a Private limited company incorporated in 2001. Its main activity is: General medical practice activities. Its registered office is in Asse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette